Does fecal microbiota transplantation reduce mortality in critically ill sepsis patients on antibiotics?

We analyzed one assertion on whether fecal microbiota transplantation reduces mortality in critically ill sepsis patients on antibiotics, and found no clear benefit. The single study reviewed did not show a statistically significant difference in 28-day mortality between those who received the transplant and those who did not [1]. The study was also too small and had imbalances between groups, making it hard to trust the results. While this one assertion supports the idea that the treatment might help, the evidence is too limited to say whether it actually does. We have no studies that contradict this finding, but we also have no strong, reliable data that confirms a benefit. What we’ve found so far suggests we cannot yet say whether fecal microbiota transplantation lowers death rates in this group. More research with larger, better-balanced studies is needed before any conclusion can be drawn. For now, the evidence remains too uncertain to guide clinical decisions.